<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02069327</url>
  </required_header>
  <id_info>
    <org_study_id>Fat Emboli</org_study_id>
    <nct_id>NCT02069327</nct_id>
  </id_info>
  <brief_title>The Role of Fat Emboli in the Trauma Inflammatory Response</brief_title>
  <official_title>The Role of Fat Emboli in the Trauma Inflammatory Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poudre Valley Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colorado State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Poudre Valley Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study designed to investigate the role of fat emboli in patients who
      are undergoing a tibial or femoral fracture procedure in the operating room. The purpose of
      this study is to obtain samples of bone marrow and blood during tibial or femoral fracture
      procedures to understand the inflammatory response.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bone marrow is routinely removed during a tibial or femoral fracture procedure; researchers
      will take samples for this study from bone marrow that has already been removed as part of
      this procedure. No additional marrow samples will be taken as part of this research study.
      Also, researchers will collect blood (about 4 teaspoons) for testing inflammatory response
      and coagulation. Researchers may need to insert an additional line to collect your blood.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory Response</measure>
    <time_frame>One day</time_frame>
    <description>Samples will be tested using proteomic and metabolomic assays from samples of bone marrow reamed during intramedullary (IM) femoral nailing.
Blood samples drawn at the time of IM nailing will be tested to determine if clinically relevant amounts of marrow containing these inflammatory mediators are released into the bloodstream.</description>
  </primary_outcome>
  <enrollment type="Actual">9</enrollment>
  <condition>Femoral Fracture</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bone marrow Blood specimen (~4 teaspoons)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a tibial or femoral fracture procedure in the operating room.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing a tibial or femoral fracture procedure in the operating room.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie Dunn, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poudre Valley Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center of the Rockies</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2014</study_first_submitted>
  <study_first_submitted_qc>February 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2014</study_first_posted>
  <last_update_submitted>July 22, 2015</last_update_submitted>
  <last_update_submitted_qc>July 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Poudre Valley Health System</investigator_affiliation>
    <investigator_full_name>Julie Dunn, M.D.</investigator_full_name>
    <investigator_title>Trauma Research Director / Trauma Surgeon</investigator_title>
  </responsible_party>
  <keyword>Femur</keyword>
  <keyword>Fat</keyword>
  <keyword>Emboli</keyword>
  <keyword>Bone</keyword>
  <keyword>Marrow</keyword>
  <keyword>proteomic</keyword>
  <keyword>proteomics</keyword>
  <keyword>metabolomics</keyword>
  <keyword>metabolomic</keyword>
  <keyword>inflammatory</keyword>
  <keyword>cytokine</keyword>
  <keyword>chemokine</keyword>
  <keyword>anaphlylatoxin</keyword>
  <keyword>Thromboelastography</keyword>
  <keyword>Medical Center of the Rockies</keyword>
  <keyword>Fat Embolism Syndrome</keyword>
  <keyword>Injury</keyword>
  <keyword>Fracture</keyword>
  <keyword>Metabolite</keyword>
  <keyword>MCR</keyword>
  <keyword>TEG</keyword>
  <keyword>FES</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Femoral Fractures</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>December 27, 2016</submitted>
    <returned>February 15, 2017</returned>
    <submitted>February 16, 2017</submitted>
    <returned>April 3, 2017</returned>
    <submitted>April 3, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

